Acutaas Chemicals Limited (NSE:ACUTAAS)

Market Cap	141.45B
Revenue (ttm)	10.97B
Net Income (ttm)	2.24B
Shares Out	81.87M
EPS (ttm)	27.38
PE Ratio	63.11
Forward PE	46.00
Dividend	1.50 (0.09%)
Ex-Dividend Date	Sep 18, 2025

Volume	421,097
Average Volume	438,330
Open	1,703.50
Previous Close	1,703.50
Day's Range	1,701.10 - 1,771.00
52-Week Range	1,059.00 - 1,868.20
Beta	-0.11
RSI	67.36
Earnings Date	Feb 14, 2026

About Acutaas Chemicals

Acutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson’s, antidepressant, and anticoagulant applications. It also provides specialty chemicals for use in battery chemicals, personal care, agrochemicals, coatings, electronics, and industrial processes; photoresist...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 2004
• Employees: 879
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ACUTAAS

Financial Performance

In 2024, Acutaas Chemicals's revenue was 10.07 billion, an increase of 40.34% compared to the previous year's 7.17 billion. Earnings were 1.59 billion, an increase of 271.06%.